The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian network that aims to improve the lives of cancer patients and those at risk for cancer by addressing challenges in the academic cancer clinical trial enterprise and improving the efficiency and quality of cancer clinical trials in Canada. Through successful execution of academic cancer clinical trials, Canadians will have access to the best available cancer treatments.
3CTN is the only Canadian network that provides direct support to cancer centres, investigators and trial teams to conduct academic cancer trials, through core and incentive funding for sites’ participation in, and recruitment to, academic cancer clinical trials.
introducing a framework and tools for sites to develop patient and public involvement programs.
3CTN is on track to meet and exceed the Year 4 goal of 50 per cent improvement over baseline in trial recruitment target, with Ontario achieving the highest increase in recruitment among all provinces (188 per cent above baseline). The overall effect is greater communication and collaboration across cancer centres in all Canadian provinces. The net results are a more vigorous academic trial environment and more academic trials addressing key questions aiming to improve outcomes for patients with cancer.
Find out more about what’s happening at the Canadian Cancer Clinical Trials Network on OICR News.
Visit 3ctn.ca for more information.